Attribution of neuropsychiatric symptoms and prioritization of evidence in the diagnosis of neuropsychiatric lupus: mixed methods analysis of patient and clinician perspectives from the international INSPIRE study

Author:

Sloan Melanie1,Andreoli Laura23ORCID,Zandi Michael S4ORCID,Harwood Rupert5,Pitkanen Mervi6,Sloan Sam7,Barrere Colette8,Massou Efthalia1,Wincup Chris9ORCID,Bosley Michael8,Naughton Felix10ORCID,Ubhi Mandeep11,Jayne David12,Leschziner Guy13,Brimicombe James1,Diment Wendy8,Middleton Kate8,Gordon Caroline11ORCID,D’Cruz David14,Pollak Thomas A6

Affiliation:

1. Department of Public Health and Primary Care Unit, University of Cambridge , Cambridge, UK

2. Unit of Rheumatology and Clinical Immunology, ASST Spedali Civili , Brescia, Italy

3. Department of Clinical and Experimental Sciences, University of Brescia , Brescia, Italy

4. Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London , London, UK

5. Swansea University Medical School , Swansea, UK

6. Institute of Psychiatry, Psychology and Neuroscience, King's College London, and South London and Maudsley NHS Foundation trust , London, UK

7. Brighton and Sussex Medical School, University of Sussex , Brighton, UK

8. Patient and Public Co-Investigators

9. Department of Rheumatology, Kings College Hospital London , London, UK

10. Behavioural and Implementation Science Group, School of Health Sciences, University of East Anglia , Norwich, UK

11. Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham , Birmingham, UK

12. Department of Medicine, University of Cambridge , Cambridge, UK

13. Department of Neurology, Guy's and St Thomas' Hospitals NHS Foundation Trust , London, UK

14. The Louise Coote Lupus Unit, Guy's and St Thomas' Hospitals NHS Foundation Trust , London, UK

Abstract

Abstract Objective Neuropsychiatric lupus (NPSLE) is challenging to diagnose. Many neuropsychiatric symptoms, such as headache and hallucinations, cannot be verified by tests or clinician assessment. We investigated prioritizations of methods for diagnosing NPSLE and attributional views. Methods Thematic and comparative analyses were used to investigate how clinicians prioritize sources of evidence from a 13-item list, and explore discordances in clinician (surveys n = 400, interviews n = 50) and patient (surveys n = 676, interviews n = 27) perspectives on attribution. Results We identified high levels of variability and uncertainty in clinicians’ assessments of neuropsychiatric symptoms in SLE patients. In attributional decisions, clinicians ranked clinicians’ assessments above diagnostic tests (many of which they reported were often unenlightening in NPSLE). Clinicians ranked patient opinion of disease activity last, and 46% of patients reported never/rarely having been asked if their SLE was flaring, despite experienced patients often having ‘attributional insight’. SLE patients estimated higher attributability of neuropsychiatric symptoms to the direct effects of SLE on the nervous system than clinicians (P < 0.001 for all symptoms excluding mania), and 24% reported that their self-assessment of disease activity was never/rarely concordant with their clinicians. Reports of misattributions were common, particularly of non-verifiable diffuse symptoms. Terminology differed between clinicians and influenced attribution estimates. Conclusion NPSLE diagnostic tests and clinician assessments have numerous limitations, particularly in detecting diffuse neuropsychiatric symptoms that can be directly attributable and benefit from immunosuppression. Our findings suggest that incorporating patient attributional insights—although also subject to limitations—may improve attribution decision-making. Consensus regarding terminology and interpretations of ‘direct attributability’ is required.

Funder

The Lupus Trust

LUPUS UK

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3